C. Hr and A. Comte-r-, Activity of epiroprim (Ro 11-8958), a Dihydrofolate reductase Inhibitor, Alone and in Combination with Dapsone, Antimicrob Agents Chemother, vol.38, pp.1803-1807, 1994.

D. M. , O. L. , C. Ma, B. Sa, and . Haller-l-&-fernex-m-, Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid on Mycobacterium tuberculo sis, Chemother, vol.47, pp.123-127, 2001.

G. Prg and J. Pa, Experimental chemotherapy of Mycobacterial diseases, Mycobacteria II chemotherapy. Chapman & Hall, pp.51-97, 1998.

L. Hh, S. H. Hartman-gp, and A. , Activities of Epiroprim, a New Dihydrofolate reductase Inhibitor, Alone and in Combination with Dapsone, Antimicrob Agents Chemother, vol.40, pp.1376-1381, 1996.

W. Sz, G. Sassan-morokro-m, A. L. Ad, and K. Jm, Efficacy of trimethoprim-sulfamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial, Lancet, vol.353, pp.1469-1475, 1999.